Neurescue has secured a historic Class III CE Mark for non‑shockable cardiac arrest treatment❤️A life-saving breakthrough for the 81% of cardiac arrest patients who cannot be defibrillated. This CE Mark bridges a gap for millions of patients facing the most critical condition.